This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Osteo Arthritis Knee
and you are
between 40 and 80
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the analgesic efficacy of V120083 twice daily compared to placebo in subjects with moderate to severe chronic pain due to OA of the knee.

Provided treatments

  • Drug: V120083
  • Drug: Naproxen
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT03028870. The sponsor of the trial is Purdue Pharma LP and it is looking for 291 volunteers for the current phase.
Official trial title:
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of V120083 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee